Abdul-Ghani M - Search Results

1

The tumor suppressor TMEM127 regulates insulin sensitivity in a tissue-specific manner.

Srikantan S, Deng Y, Cheng ZM, Luo A, Qin Y, Gao Q, Sande-Docor GM, Tao S, Zhang X, Harper N, Shannon CE, Fourcaudot M, Li Z, Kasinath BS, Harrison S, Ahuja S, Reddick RL, Dong LQ, Abdul-Ghani M, Norton L, Aguiar RCT, Dahia PLM. Srikantan S, et al. Nat Commun. 2019 Oct 17;10(1):4720. doi: 10.1038/s41467-019-12661-0. Nat Commun. 2019. PMID: 31624249 Free PMC article.

2

Pathogenesis of insulin resistance in skeletal muscle.

Abdul-Ghani MA, DeFronzo RA. Abdul-Ghani MA, et al. J Biomed Biotechnol. 2010;2010:476279. doi: 10.1155/2010/476279. Epub 2010 Apr 26. J Biomed Biotechnol. 2010. PMID: 20445742 Free PMC article. Review.

3

The relationship between {beta}-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology study.

Kanat M, Winnier D, Norton L, Arar N, Jenkinson C, Defronzo RA, Abdul-Ghani MA. Kanat M, et al. Diabetes Care. 2011 Apr;34(4):1006-10. doi: 10.2337/dc10-1352. Epub 2011 Feb 23. Diabetes Care. 2011. PMID: 21346184 Free PMC article.

4

Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.

Kanat M, Norton L, Winnier D, Jenkinson C, DeFronzo RA, Abdul-Ghani MA. Kanat M, et al. Acta Diabetol. 2011 Sep;48(3):209-17. doi: 10.1007/s00592-011-0285-x. Epub 2011 May 8. Acta Diabetol. 2011. PMID: 21553243 Clinical Trial.

5

Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes.

Abdul-Ghani MA, Norton L, Defronzo RA. Abdul-Ghani MA, et al. Endocr Rev. 2011 Aug;32(4):515-31. doi: 10.1210/er.2010-0029. Epub 2011 May 23. Endocr Rev. 2011. PMID: 21606218 Review.

6

Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism.

Norton L, Fourcaudot M, Abdul-Ghani MA, Winnier D, Mehta FF, Jenkinson CP, Defronzo RA. Norton L, et al. Diabetologia. 2011 Dec;54(12):3132-42. doi: 10.1007/s00125-011-2289-z. Epub 2011 Sep 7. Diabetologia. 2011. PMID: 21901280

7

Distinct β-cell defects in impaired fasting glucose and impaired glucose tolerance.

Kanat M, Mari A, Norton L, Winnier D, DeFronzo RA, Jenkinson C, Abdul-Ghani MA. Kanat M, et al. Diabetes. 2012 Feb;61(2):447-53. doi: 10.2337/db11-0995. Diabetes. 2012. PMID: 22275086 Free PMC article.

8

Efficacy and safety of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus.

Abdul-Ghani MA, Norton L, DeFronzo RA. Abdul-Ghani MA, et al. Curr Diab Rep. 2012 Jun;12(3):230-8. doi: 10.1007/s11892-012-0275-6. Curr Diab Rep. 2012. PMID: 22528597 Review.

9

Novel hypothesis to explain why SGLT2 inhibitors inhibit only 30-50% of filtered glucose load in humans.

Abdul-Ghani MA, DeFronzo RA, Norton L. Abdul-Ghani MA, et al. Diabetes. 2013 Oct;62(10):3324-8. doi: 10.2337/db13-0604. Diabetes. 2013. PMID: 24065789 Free PMC article.

10

Strong association between insulin-mediated glucose uptake and the 2-hour, not the fasting plasma glucose concentration, in the normal glucose tolerance range.

Winner D, Norton L, Kanat M, Arya R, Fourcaudot M, Hansis-Diarte A, Tripathy D, DeFronzo RA, Jenkinson CP, Abdul-Ghani M. Winner D, et al. J Clin Endocrinol Metab. 2014 Sep;99(9):3444-9. doi: 10.1210/jc.2013-2886. Epub 2014 May 5. J Clin Endocrinol Metab. 2014. PMID: 24796924 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters